InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Atlas Venture Fund X, LP. Officer active across 2 companies, notably Kymera Therapeutics, Inc.. In total, 10 reports have been recorded. Activity tracked since 17 June 2026. The latest transaction was disclosed on 4 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Atlas Venture Fund X, LP is a declarant and a shareholder of Kymera Therapeutics, Inc. (XNAS). The record shows 8 filings in total, with recent filings from 2026-06-17 to 2026-06-29, all related to sales, for a combined amount of EUR 135176887 across the sampled filings, and the modal transaction nature is Notice of proposed sale (Form 144).